Methodological Issues on the Study of Eosinopenia as an Adverse Marker of Clinical Outcomes in Patients With Acute Myocardial Infarction
- PMID: 32741453
- DOI: 10.1016/j.amjmed.2020.02.006
Methodological Issues on the Study of Eosinopenia as an Adverse Marker of Clinical Outcomes in Patients With Acute Myocardial Infarction
Comment in
-
The Reply.Am J Med. 2020 Aug;133(8):e447. doi: 10.1016/j.amjmed.2020.03.014. Am J Med. 2020. PMID: 32741454 No abstract available.
Comment on
-
Eosinopenia as an Adverse Marker of Clinical Outcomes in Patients Presenting with Acute Myocardial Infarction.Am J Med. 2019 Dec;132(12):e827-e834. doi: 10.1016/j.amjmed.2019.05.021. Epub 2019 May 30. Am J Med. 2019. PMID: 31152721
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
